Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: Nashville TN, Atlanta GA, Athens GA, St Louis MO,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06827236

Phase1, Phase2, Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

for
Carcinoma, Non-Small Cell Lung,
Location: Nashville TN, Indianapolis IN, Springfield IL,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04389632

Phase1, Recruiting

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

for
NHL, Multiple Myeloma, Blood Cancer,
Location: Nashville TN, Atlanta GA, Winston-Salem NC,
Sponsor: Indapta Therapeutics, INC.

Sex: All

Age: 18+

Code: NCT06119685

Phase1, Phase2, Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

for
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Location: Nashville TN, Atlanta GA, Cincinnati OH, St Louis MO,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06765109

Phase3, Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
Location: Nashville TN, Birmingham AL, Atlanta GA, Cincinnati OH,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 12+

Code: NCT02693535

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: Nashville TN, St Louis MO, Chicago IL, Baltimore MD,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06172478

Phase2, Recruiting

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Nashville TN, Memphis TN, Asheville NC, Dayton OH,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT05920356

Phase3, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Nashville TN, Atlanta GA, Germantown TN, Chicago IL,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC),
Location: Nashville TN, New Orleans LA, Grand Rapids MI,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06784193

Phase1, Recruiting

QTX3034 in Patients With KRAS G12D Mutation

for
Solid Tumors
Location: Nashville TN, Durham NC, Fairfax VA, Tampa FL,
Sponsor: Quanta Therapeutics

Sex: All

Age: 18+

Code: NCT06227377

Phase1, Recruiting

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

for
Breast Cancer, Gastric Cancer, Esophageal Cancer,
Location: Nashville TN, Dallas TX, Houston TX, New York NY,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06695845

Phase2, Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Colorectal Cancer
Location: Nashville TN, Louisville KY, Atlanta GA, Ann Arbor MI,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06004245

Phase1, Recruiting

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Nashville TN, Denver CO, St Louis MO, Columbus OH,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06521554

Phase1, Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

for
MTAP-deleted Solid Tumors
Location: Nashville TN, Grand Rapids MI, Orlando FL, Irving TX,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06914128

Phase1, Phase2, Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Nashville TN, Denver CO, St Louis MO, Columbus OH,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06120283

Phase1, Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: Nashville TN, St Louis MO, Cleveland OH, Madison WI,
Sponsor: HiberCell, Inc.

Sex: All

Age: 18+

Code: NCT06234605

Phase1, Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Nashville TN, Cincinnati OH, Indianapolis IN,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase2, Recruiting

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

for
Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Location: Nashville TN, Evansville IN, Birmingham AL,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT00271180

Recruiting

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: Nashville TN, Birmingham AL, Columbus OH,
Sponsor: DynamiCure Biotechnology

Sex: All

Age: 18+

Code: NCT05785754

Phase1, Recruiting

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: Nashville TN, Myrtle Beach SC, Oklahoma City OK,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT03460977

Phase1, Recruiting